Shenzhen Mille Youpin E-commerce Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Mille Youpin E-commerce Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include EZZOV. The owner is based in Longhua,Shenzhen.

709 A02,No.23,North District,Fuquan New

Village,Sanlian Community,Longhua Street

Longhua,Shenzhen 518110 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EZZOV
EZZOV
Registered 2020

Trademark Classifications

Shenzhen Mille Youpin E-commerce Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Mille Youpin E-commerce Co., Ltd. have?

Shenzhen Mille Youpin E-commerce Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Mille Youpin E-commerce Co., Ltd. file in?

Shenzhen Mille Youpin E-commerce Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Mille Youpin E-commerce Co., Ltd.'s most well-known trademarks?

Shenzhen Mille Youpin E-commerce Co., Ltd.'s registered trademark portfolio includes well-known marks such as EZZOV. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Mille Youpin E-commerce Co., Ltd.'s trademark registration success rate?

Shenzhen Mille Youpin E-commerce Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.